Standout Papers

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies 2021 2026 2022 2024555
  1. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021)
    Markus Hoffmann, Prerna Arora et al. Cell
  2. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic (2021)
    Markus Hoffmann, Nadine Krüger et al. Cell
  3. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency (2024)
    Lu Zhang, Amy Kempf et al. Cell

Immediate Impact

14 by Nobel laureates 22 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
2022 StandoutScience
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
2022 Standout
8 intermediate papers

Works of Hans‐Martin Jäck being referenced

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
2021 Standout
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
2021
and 1 more

Author Peers

Author Last Decade Papers Cites
Hans‐Martin Jäck 2241 2643 592 1661 150 6.4k
Scott D. Boyd 3145 2141 808 682 118 6.6k
Elizabeth J. Soilleux 2011 1522 282 1778 99 5.5k
Wilfried Ellmeier 4513 2624 295 1070 95 7.9k
Meng Wang 1587 1806 912 1001 122 4.5k
Peter D. Katsikis 4076 1864 797 560 133 7.7k
William V. Williams 2329 2176 884 873 158 6.0k
Dean L. Mann 5103 2156 1148 1267 185 10.0k
Bruce E. Torbett 2970 3432 225 896 143 7.9k
Paul Jolicoeur 2551 3249 415 1358 173 7.5k
Jocelyne Demengeot 3685 2070 330 442 81 6.5k

All Works

Loading papers...

Rankless by CCL
2026